Hazlett Burt & Watson Inc. Grows Stock Position in Astera Labs, Inc. $ALAB

Hazlett Burt & Watson Inc. increased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 97.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,748 shares of the company’s stock after buying an additional 863 shares during the period. Hazlett Burt & Watson Inc.’s holdings in Astera Labs were worth $159,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Fred Alger Management LLC boosted its position in shares of Astera Labs by 13.0% in the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after buying an additional 179,638 shares in the last quarter. Hoey Investments Inc. boosted its stake in shares of Astera Labs by 22.4% during the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after purchasing an additional 1,121 shares during the last quarter. Wealth Effects LLC acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $242,000. Realta Investment Advisors purchased a new stake in shares of Astera Labs during the second quarter worth about $214,000. Finally, Sheets Smith Wealth Management acquired a new position in shares of Astera Labs in the second quarter valued at approximately $481,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Stock Performance

Shares of ALAB stock opened at $199.53 on Tuesday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company has a 50 day moving average price of $199.95 and a 200 day moving average price of $125.97. The firm has a market capitalization of $33.17 billion, a price-to-earnings ratio of 356.30, a price-to-earnings-growth ratio of 5.14 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the prior year, the business posted $0.13 earnings per share. Astera Labs’s revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the transaction, the chief operating officer directly owned 5,525,545 shares of the company’s stock, valued at $939,453,160.90. The trade was a 4.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the sale, the director owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,308,772 shares of company stock worth $214,482,678. 12.50% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective for the company. in a research report on Tuesday, July 22nd. Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Bank of America assumed coverage on shares of Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price objective for the company. CICC Research assumed coverage on shares of Astera Labs in a research report on Friday, August 29th. They issued an “outperform” rating and a $190.00 price objective for the company. Finally, Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $159.83.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.